Publicaciones en las que colabora con María Blanco Prieto (18)

2013

  1. Hydrophobic gentamicin-loaded nanoparticles are effective against Brucella melitensis infection in mice

    Antimicrobial Agents and Chemotherapy, Vol. 57, Núm. 7, pp. 3326-3333

2012

  1. Cellular pharmacokinetics and intracellular activity against Listeria monocytogenes and Staphylococcus aureus of chemically modified and nanoencapsulated gentamicin

    Journal of Antimicrobial Chemotherapy, Vol. 67, Núm. 9, pp. 2158-2164

2011

  1. Development and validation of ultra high performance liquid chromatography-mass spectrometry method for LBH589 in mouse plasma and tissues

    Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, Vol. 879, Núm. 30, pp. 3490-3496

  2. High loading of gentamicin in bioadhesive PVM/MA nanostructured microparticles using compressed carbon-dioxide

    Pharmaceutical Research, Vol. 28, Núm. 2, pp. 309-321

  3. Novel bioactive hydrophobic gentamicin carriers for the treatment of intracellular bacterial infections

    Acta Biomaterialia, Vol. 7, Núm. 4, pp. 1599-1608

2010

  1. Drug delivery systems for potential treatment of intracellular bacterial infections

    Frontiers in Bioscience, Vol. 15, Núm. 2, pp. 397-417

2008

  1. Applications of particulate drug delivery systems in the control of an intracellular bacterial pathogen

    Handbook of particulate drug delivery (American Scientific Publishers), pp. 325-346

2007

  1. Biodegradable gentamicin delivery systems for parenteral use for the treatment of intracellular bacterial infections

    Expert Opinion on Drug Delivery, Vol. 4, Núm. 6, pp. 677-688

  2. Nanoparticles as adjuvant-vectors for vaccination

    Nanoparticulate Drug Delivery Systems (CRC Press), pp. 317-325

  3. Poly(D,L-lactide-coglycolide) particles containing gentamicin: Pharmacokinetics and pharmacodynamics in Brucella melitensis-infected mice

    Antimicrobial Agents and Chemotherapy, Vol. 51, Núm. 4, pp. 1185-1190

2006

  1. Biodegradable micro- and nanoparticles as long-term delivery vehicles for gentamicin

    Journal of Microencapsulation, Vol. 23, Núm. 7, pp. 782-792

  2. Chemical and biological factors in the control of Brucella and brucellosis

    Current Drug Delivery, Vol. 3, Núm. 4, pp. 359-365

  3. Determination of gentamicin in different matrices by a new sensitive high-performance liquid chromatography-mass spectrometric method

    Journal of Antimicrobial Chemotherapy, Vol. 58, Núm. 3, pp. 557-563

  4. Intracellular killing of Brucella melitensis in human macrophages with microsphere-encapsulated gentamicin

    Journal of Antimicrobial Chemotherapy, Vol. 58, Núm. 3, pp. 549-556

  5. Nanocarriers with gentamicin to treat intracellular pathogens

    Journal of Nanoscience and Nanotechnology

2004

  1. New therapeutic approaches for the treatment of Brucella infections: Gentamicin entrapment into drug delivery systems

    Current Medicinal Chemistry: Anti-Infective Agents, Vol. 3, Núm. 1, pp. 43-56

2002

  1. Development of microparticles prepared by spray-drying as a vaccine delivery system against brucellosis

    International Journal of Pharmaceutics, Vol. 242, Núm. 1-2, pp. 341-344

  2. In vitro evaluation of gentamicin released from microparticles

    International Journal of Pharmaceutics, Vol. 242, Núm. 1-2, pp. 203-206